KRAS and sarcoma: YAP1 S127A and KRAS G12V-Cdkn2a null-driven ERMS repress the expression of mostly different gene sets in sarcomas compared to differentiated skeletal muscle, but again approximately 20% (100 genes) of the down regulated genes are identical.